Next-Generation Sequencing for Patients: What Test Will I Get?
This fact sheet describes some of the panels used to detect genomic aberrations and guide treatment decisions.
All articles by Andrea S. Blevins Primeau, PhD, MBA
Adverse Events Associated With Outcomes in PD-1/PD-L1–Treated Urothelial Carcinoma
An FDA pooled analysis suggests that certain AEs were associated with response and overall survival in PD-1/PD-L1-treated urothelial cancer.
Synthetic Control Arm Replicates Outcomes From Historical Data
A synthetic control arm based on pooled historical data successfully replicated clinical outcomes.
Osimertinib Associated With Higher Rates of Cardiotoxicity Than Other EGFR TKIs
A FAERS analysis demonstrated that osimertinib is associated with increased odds of developing cardiotoxicities compared with other EGFR TKIs.
Potential Factors Associated With Early Mortality With Immunotherapy
An FDA analysis of pooled data identified potential factors associated with unexplained early mortality in immunotherapy arms of clinical trials.
Use of Alternative Medicine as a Replacement for Conventional Cancer Treatment
This fact sheet describes the known effects of forgoing conventional anticancer therapy in favor of alternative treatment approaches.
Barriers to Cancer Clinical Trial Enrollment
This fact sheet discusses potential barriers to participation in cancer clinical trials.
Yoga and Cancer
This fact sheet reviews the use of yoga as a supportive care tool for patients with cancer.
Probiotics and Cancer
Microbial-derived factors can promote or suppress tumorigenesis and may modulate the efficacy of anticancer treatments.
Sunscreen Use and Cancer
This fact sheet reviews data on the use of sunscreen and the risk of nonmelanoma and melanoma skin cancers.
Next post in Fact Sheets
